CSIMarket Company Name, Ticker, Suppliers, else..
 
Zura Bio Limited  (NASDAQ: ZURA)
 

Zura Bio Limited's Suppliers Performance

ZURA's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
ZURA Costs vs Sales of Suppliers Growth

• More on ZURA Suppliers






Zura Bio Limited's Comment on Supply Chain


The company utilizes contract manufacturers in Italy and the Netherlands to produce tibulizumab drug substance and finished drug product in compliance with cGMP. Lilly previously manufactured tibulizumab before the company in-licensed it and holds a license to the manufacturing process and analytical testing from Lilly. In 2024, torudokimab manufacturing was relocated from WuXi in the People's Republic of China to the United Kingdom, with WuXi remaining involved in an ongoing stability study. Due to increased U.S. government scrutiny of WuXi and the PRC, the company may need to select a new manufacturer and conduct additional stability studies, which could affect the supply of torudokimab.

Zura Bio Limited's Comment on Supply Chain


The company utilizes contract manufacturers in Italy and the Netherlands to produce tibulizumab drug substance and finished drug product in compliance with cGMP. Lilly previously manufactured tibulizumab before the company in-licensed it and holds a license to the manufacturing process and analytical testing from Lilly. In 2024, torudokimab manufacturing was relocated from WuXi in the People's Republic of China to the United Kingdom, with WuXi remaining involved in an ongoing stability study. Due to increased U.S. government scrutiny of WuXi and the PRC, the company may need to select a new manufacturer and conduct additional stability studies, which could affect the supply of torudokimab.







ZURA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Zura Bio Limited 522.43 0.00 -111.58 40
SUBTOTAL 0.00 0.00 0.00 -


Sources: Zura Bio Limited's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Zura Bio Limited’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.